Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / I•••••••• P•••••• L••••••

W•••••• P••••• Acquires I••••••••, an Orthopedics and Gynecology-Focused Pharmaceuticals Company Jul 15, 2026

Platform acquisitionannouncedannounced Jul 15, 2026Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
2 named
Buy side
  • W•••••• P•••••, the pioneer of global growth investing, today announced the acquisition of I•••••••• P•••••• L•••••• (“I••••••••” or the “Company”), a leading domestic formulations company focused on orthopedics and gynecology. | published on W•••••• P•••••'s own news page warburgpincus.com
Side not stated
  • W•••••• P•••••, the pioneer of global growth investing, today announced the acquisition of I•••••••• P•••••• L•••••• (“I••••••••” or the “Company”), a leading domestic formulations company focused on orthopedics and gynecology.
Evidence
W•••••• P•••••, the pioneer of global growth investing, today announced the acquisition of I•••••••• P•••••• L•••••• (“I••••••••” or the “Company”), a leading domestic formulations company focused on orthopedics and gynecology.
W•••••• P••••• Acquires I••••••••, an Orthopedics and Gynecology-Focused Pharmaceuticals C | Private Equity Intelligence | DFX